Yong-qian Jiang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Severe and life-threatening side effects can occur in patients receiving allergen-specific immunotherapy (SIT), and recombinant allergens made from cDNA have been used in clinical trials for ten years and appear promising for SIT. The aim of this study is to explore the effects of the recombinant allergen Der f 2 (the group 2 allergen from Dermatophagoides(More)
  • 1